ANIP ANI PHARMACEUTICALS INC Investor Conferences 8-K Filing 2024 - Panel Discussion at Biotech/Biopharma Disruptors Event Nikhil Lalwani, President & CEO of ANI Pharmaceuticals, Inc., participated in a panel discussion at the Capital One Securities 1st Annual Biotech/Biopharma Disruptors Event in New York City.Get access to all SEC 8-K filings of the ANI PHARMACEUTICALS INC